S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7228 −0.33%
CLOSED · 18:40 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today303 insider buys this week · $300.8MCIRO short report next: Sep 15The week ahead
CN
INSIDER · CMMB · Chemomab Therapeutics Ltd. · DIRECTOR

Cohen Neil Harris

Every open-market transaction filed under this name, Aug 27 to Aug 28.

Filings
2
0 buys · 2 sells
Bought
open market, at cost
Sold
$7K
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 28CMMBChemomab Therapeutics Ltd.DirectorSell1,000$2.80$3K
Aug 27CMMBChemomab Therapeutics Ltd.DirectorSell1,304$2.85$4K

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.